Mimedx (MDXG) EBITDA Margin (2009 - 2026)
Mimedx (MDXG) posted EBITDA Margin of -18.19% for Q3 2026, down 38.21 percentage points from 20.01% a year earlier but up 9.81 percentage points from the prior quarter.
Powered by 
Analysis
Mimedx (MDXG) EBITDA Margin (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EBITDA Margin at Mimedx was -7.65%, down 22.02 percentage points year-over-year; for FY2025, it came in at 18.82%, down 0.01 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +33.43 percentage points (FY2020 to FY2025).
- In prior years, Mimedx's EBITDA Margin was 18.82% in FY2024 (+5.82 pp), 13.01% in FY2023 (+16.82 pp), -3.81% in FY2022 (-3.48 pp) and -0.34% in FY2021 (+14.27 pp).
- Quarterly EBITDA Margin has run from a low of -28.01% in Q2 2026 to a high of 27.75% in Q2 2024 over five years.
- On a year-over-year basis, EBITDA Margin has declined in each of the last three quarters, with an average year-over-year change of -16.45 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2023, with a gain of 27.26 percentage points; the weakest was Q2 2026, with a drop of 41.12 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -28.01% (Q2 2026), -26.31% (Q1 2026) and 18.33% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 20.05% |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 9.79% |
| 10 | Mimedx | 491.77 Mn | -90.75 Mn | 49.70 Mn | -18.40% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -18.40% |
| Jun 30, 2026 | -28.01% |
| Mar 31, 2026 | -26.31% |
| Dec 31, 2025 | 18.33% |
| Sep 30, 2025 | 20.01% |
| Jun 30, 2025 | 12.97% |
| Mar 31, 2025 | 10.25% |
| Dec 31, 2024 | 11.29% |
| Sep 30, 2024 | 15.77% |
| Jun 30, 2024 | 26.41% |
| Mar 31, 2024 | 16.54% |
| Dec 31, 2023 | 18.92% |
| Sep 30, 2023 | 14.80% |
| Jun 30, 2023 | 14.57% |
| Mar 31, 2023 | 0.96% |
| Dec 31, 2022 | 16.68% |
| Sep 30, 2022 | -8.83% |
| Jun 30, 2022 | -12.69% |
| Mar 31, 2022 | -13.85% |
| Dec 31, 2021 | 5.00% |
API Access
Mimedx EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MDXG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "MDXG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=MDXG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();